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Response bias to a randomised controlled
trial of a lifestyle intervention in people at
high risk of cardiovascular disease: a cross-
sectional analysis
Adam Bayley1, Daniel Stahl2, Mark Ashworth3, Derek G. Cook4, Peter H. Whincup4, Janet Treasure5,
Anne Greenough6,7,8, Katie Ridge1, Kirsty Winkley1 and Khalida Ismail1*
Abstract
Background: Research evaluating lifestyle interventions for prevention of cardiovascular disease (CVD) may not
reach those most at risk. We compared the response rate to a randomised controlled trial (RCT) of a lifestyle
intervention by CVD risk, ethnicity and level of deprivation.
Methods: Primary care patients with a QRisk2 score ≥ 20% were invited to participate in a RCT of an intensive
lifestyle intervention versus usual care. This cross-sectional analysis compares anonymised data of responders and
non-responders with multiple logistic regression, using adjusted odds ratios (AORs) for QRisk2 score, ethnicity, Index
of Multiple Deprivation (IMD 2010) quintile, age and sex.
Results: From 60 general practices, 8902 patients were invited and 1489 responded. The mean age was 67.3 years
and 21.0% were female. Of all patients invited, 69.9% were of white ethnic background, 13.9% ethnic minority
backgrounds and 16.2% had no ethnicity data recorded in their medical records. Likelihood of response decreased
as QRisk2 score increased (AOR 0.82 per 5 percentage points, 95% CI 0.77–0.88). Black African or Caribbean patients
(AOR 0.67; 95% CI 0.45–0.98) and those with missing ethnicity data (AOR 0.55; 95% CI 0.46–0.66) were less likely
to respond compared to participants of white ethnicity, but there was no difference in the response rates between
south Asian and white ethnicity (AOR 1.08; 95% CI 0.84–1.38). Patients residing in the fourth (AOR 0.70; 95% CI 0.56–0.87)
and fifth (AOR 0.52; 95% CI 0.40–0.68) most deprived IMD quintile were less likely to respond compared to the least
deprived quintile.
Conclusions: Evaluations of interventions intended for those at high risk of CVD may fail to reach those at highest risk.
Hard to reach patient groups may require different recruitment strategies to maximise participation in future trials.
Improvements in primary care ethnicity data recording is required to aid understanding of how successfully study
samples represent the target population.
Trial registration: ISRCTN, ISRCTN84864870. Registered 15 May 2012, https://doi.org/10.1186/ISRCTN84864870.
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Background
Cardiovascular disease (CVD) is the most common
cause of mortality in developed nations [1]. Modifiable
risk factors for CVD include tobacco use, physical in-
activity, obesity and raised low-density lipoprotein (LDL)
cholesterol [2–4]. Those most at risk are older males, of
south Asian ethnic background, with lower educational
attainment and lower socioeconomic status [5, 6]. Life-
style intervention trials for primary prevention of CVD
are a research priority [7–9], but previous trials have re-
ported low participation rates [10, 11].
Factors associated with increased participation in
intervention trials to increase walking and physical activ-
ity include white ethnicity, living in more affluent areas,
middle age, female sex and university education [11, 12],
although methodological factors can lead to different
participation biases across trials. Whilst some previous
trials have observed that those of poorest health are the
most likely to respond [11, 13–15], others report that
participants are healthier and more active than
non-participants [10, 14, 16, 17]. Participation of ethnic
minorities is important as they are at higher risk for
CVD and type 2 diabetes [18]. Failure to recruit subjects
at highest risk of disease may limit representativeness,
underestimate effect sizes, and could lead to the imple-
mentation of interventions which increase rather than
decrease health inequalities. Yet, there are few opportun-
ities to study participation biases as those who do not
respond to invitations to participate typically have not
given consent to medical data access [19].
In this study we tested the hypothesis that people who
have a lower risk of CVD are more likely to respond to an
invite to participate in a randomised controlled trial
(RCT) evaluating an intensive lifestyle intervention for re-
ducing weight and increasing physical activity. We also
tested whether potential sociodemographic markers of re-
sponse such as white ethnicity and living in more affluent
areas corresponded to a greater likelihood of response.
Methods
Setting and design
We used a cross-sectional design. The sample was de-
rived from the target population invited for eligibility
screening to participate in a RCT assessing the effective-
ness of an enhanced MOtiVational intErviewing InTer-
vention (MOVE IT) for reducing weight and increasing
physical activity in people at high risk of CVD. MOVE
IT compares the effectiveness of motivational interview-
ing (MI) and cognitive behaviour therapy (CBT) behav-
iour change techniques in group, individual and usual
care arms. The study population consisted of patients at
high risk of CVD in primary care from 12 south London
Clinical Commissioning Groups (CCGs) representing an
ethnically-diverse resident population of about 3 million
[20]. Further details are described in the trial protocol
[21]. Ethical approval for the MOVE IT trial was granted
by the Dulwich ethics committee (12/LO/0917), includ-
ing permission to extract anonymised data for all pa-
tients invited to participate. Data were not extracted if
the patient record included an informed dissent code,
indicating that patient data should not be shared with a
third party.
Participants and case definition
Participating practices screened primary care databases
for eligible patients using either EMIS (EMIS Health,
Leeds, UK) or Vision (In Practice Systems, London, UK)
medical records systems, two of the clinical software
programmes most commonly used in UK primary care.
The risk of CVD was calculated using QRisk2 (QRe-
search, Nottingham, UK), a validated predictive tool for
identifying the percentage risk of having a fatal or
non-fatal cardiovascular event in the next 10 years [6].
Registered patients with a QRisk2 score estimated on
medical records to be ≥20% and aged 40–74 years were
invited to participate via a standardised letter from their
general practitioner (see Additional file 1) which also in-
cluded a participant information sheet (see Additional file 2).
Patients were given a choice of response methods: either
returning a reply slip in a stamped and addressed envelope
following which a research assistant would telephone to ar-
range an appointment time, or to telephone the research
team directly. Patients were excluded from the invitation if
their medical records included a Read code (a coded the-
saurus of clinical terms used in UK primary care databases)
for past diagnosis of CVD, diabetes, kidney disease, chronic
obstructive pulmonary disease, disabling neurological dis-
order, severe mental illness, registered blind or housebound,
currently pregnant, advanced cancer or a body mass index
> 50 kg/m2.
Measures
The measures collected anonymously for patients invited to
participate were QRisk2 score, ethnicity, postcode, age (at
time of screening) and sex. QRisk2 score was estimated on
medical records via a batch calculator which uses an algo-
rithm of risk factors [6]. The variables used by the QRisk2
algorithm are age, sex, ethnicity, deprivation calculated
from postcode data, smoking status, diabetes status,
rheumatoid arthritis status, chronic kidney disease status,
atrial fibrillation status, hypertensive treatment status,
family history of CVD, body mass index (BMI), systolic
blood pressure and the ratio of high-density lipoprotein
cholesterol to total cholesterol. The algorithm uses age-
and sex-based national averages for missing data values.
Self-report ethnicity data on medical records includes
a wide variety of categories, some of which are not
clearly defined. Where possible, data were grouped into
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white, black African or Caribbean, south Asian, other
Asian, other/mixed or missing. South Asian and other
Asian are coded separately as a higher CVD risk is asso-
ciated with south Asian ethnicity [6]. The category
other/mixed incorporates any ethnicity which is reported
and does not fit into the previous categories, as well as
indication of mixed ethnic background.
Postcode data were collected in order to calculate Index
of Multiple Deprivation 2010 (IMD 2010; based on Lower
Layer Super Output Area (LSOA)) [22]. The IMD 2010
incorporates seven domains: income deprivation, employ-
ment deprivation, health deprivation and disability, educa-
tion deprivation, crime, barriers to housing and services,
and living environment. All small areas in England are
ranked, from 1 (most deprived) to 32,482, and data can be
grouped into quintiles.
Statistical analysis
Data are summarised as means and standard deviations
(SD), or as percentages. The median IMD ranks are
compared between responders and non-responders. In
the unadjusted model, the odds of response were calcu-
lated for each explanatory variable separately. In the ad-
justed model, the odds of response were calculated via
logistic regression adjusting for potential confounding by
QRisk2 score, ethnicity, IMD quintile, age and sex in
Stata version 14 (StataCorp, Texas, USA). General prac-
tice was included as a random effect in the model to
allow for clustering by practice. Adjusted odds ratios
(AORs) for age are presented per 5 year increase and for
QRisk2 scores per 5 percentage point increase to provide
a better comparison of the strength of the relationships.
Results
General practice and participant recruitment
We invited all 302 general practices with a patient list
size of 5000 or more in the 12 south London CCGs, and
9 general practices with a < 5000 patient list size re-
cruited to increase participation; 134 general practices
agreed to participate and were recruited between June
2013 and December 2014. The medical records data of
1,154,050 patients were screened for eligibility and
17,618 patients were potentially eligible and invited to
screening for eligibility, representing the target study
population of whom 3515 patients responded (response
rate 20.0%). See Fig. 1 for the patient response and
anonymised data collection flow chart.
We returned to general practices to extract anonymous
data following the requirements of ethical approval. The ori-
ginal list of potentially eligible patients who had been invited
to participate had been deleted from primary care databases
at many general practices; 60 practices were still able to pro-
vide the original anonymised data totaling 8902 patients
(50.5% of the target population). No exclusions of data were
made based on informed dissent for data sharing with a third
party as no informed dissent codes were identified during
the search and data extraction. Socio-demographic data and
QRisk2 scores were extracted. Table 1 shows the CCGs from
which anonymised data were collected and the deprivation
and ethnicity Census data of each local authority [20].
General practice deprivation varies markedly within and be-
tween the CCGs, but population-weighted general practice
deprivation scores (IMD 2010) of those practices from which
anonymised data were extracted did not differ significantly
from that of all other practices in south London (t (440) =
0.57, p= 0.57) [23].
Fig. 1 Patient response and anonymised data collection flow chart
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Participation biases
The QRisk2 and sociodemographic data of responders (n =
1489) and non-responders (n = 7413), and the results of the
adjusted logistic regression, are presented in Table 2. The
mean QRisk2 score of all patients invited to participate was
25.2%, and 69.9% were of white ethnic background (13.9%
were of non-white ethnic background and 16.2% had no
ethnicity data recorded). The median (interquartile range)
IMD 2010 rank for all patients was 13,489 (7618–22,804).
The mean age of all patients at the time of invite was 67.3
(5.7) years, and 20.7% were female.
As CVD risk increased the odds of response decreased
(AOR 0.82 per 5 percentage points; 95% CI 0.77–0.88);
for every 5 point increase in QRisk2 score the odds of
responding decreased by 18%. Response was lower in pa-
tients of black African or Caribbean ethnicity (AOR
0.67; 95% CI 0.45–0.98) and those with missing ethnicity
data (AOR 0.55; 95% CI 0.46–0.66) compared to white
ethnicity. The odds of response from Asian and other
ethnic backgrounds were not significantly different to
that of patients of white ethnicity. A median test found
the IMD ranks of responders (15,314; 9285–24,774) was
significantly higher than non-responders (12,854; 7411–
22,330) (p < 0.001). The odds of response in the fourth
(AOR 0.70; 95% CI 0.56–0.87) and fifth (AOR 0.52; 95%
CI 0.40–0.68) most deprived quintiles were significantly
lower than the least deprived quartile. Response was
higher with increasing age (AOR 1.19 per 5 years; 95%
CI 1.12–1.26); the odds of responding increased by 19%
for each 5 year increase in age. Odds of responding were
higher in male compared to female patients (AOR 1.25;
95% CI 1.08–1.45).
Pairwise comparisons were conducted to explore differ-
ences in response between each of the non-white ethnic
groups, but there were no significant differences. Response
rates of patients with missing ethnicity data were signifi-
cantly lower than that of patients of south Asian ethnicity
(p = 0.002). Due to small numbers of invitations to pa-
tients of non-white ethnicity, a sensitivity analysis was
undertaken to investigate predictors of response to invita-
tion with ethnicity removed from the model. Lower CVD
risk (p < 0.001), lower levels of deprivation (p = 0.001),
older age (p < 0.001) and male sex (p = 0.015) remained
significant predictors of response.
Discussion
In this cross-sectional study of response to an invitation
to take part in a RCT of an intensive lifestyle interven-
tion for primary prevention of CVD, we found that like-
lihood of response reduced with increasing CVD risk in
a population who were all at high risk of CVD. Black Af-
rican or Caribbean patients were less likely to respond
than those of white ethnicity, although there were small
numbers of black African or Caribbean patients invited.
South Asian patients were as likely to respond as those
of white ethnicity. We also observed high rates of
Table 1 GP practice recruitment and data collection by Clinical Commissioning Group
Clinical Commissioning Group
Bexley Bromley Croydon Greenwich Kingston Lambeth Lewisham Merton Richmond Southwark Sutton Wandsworth
Total GP practices
recruited
8 22 14 14 6 9 16 10 5 16 8 6
EMIS practices 1 22 13 2 2 9 16 9 0 16 7 6
Vision practices 7 0 1 12 4 0 0 1 5 0 1 0
Borough
deprivation (IMD
2010 rank)a
180 217 99 19 252 14 16 208 286 25 193 102
Borough ethnicity (%)b
White 81.9 84.3 55.2 62.5 74.5 57.1 53.6 64.9 85.9 54.3 78.6 71.4
Black African or
Caribbean
8.5 6.0 20.2 19.1 2.4 25.9 27.2 10.4 1.5 26.8 4.8 10.6
South Asian 3.6 2.7 10.5 4.7 6.5 3.3 2.8 8.9 3.9 4.0 5.4 6.5
Other Asian 2.9 2.5 5.9 7.0 9.9 3.5 6.5 9.2 3.4 5.5 6.2 4.4
Other/Mixed 3.0 4.5 8.4 6.7 6.6 10.1 10.0 6.5 5.2 9.4 5.0 7.1
Anonymous data collected
GP practices 1 11 11 1 1 6 11 2 0 9 3 4
Patients 328 2463 1663 255 27 845 1281 41 0 666 786 646
IMD Index of Multiple Deprivation
Data presented is n unless otherwise stated
aRanked from 1 (most deprived) to 326 (least deprived) from 326 Local Authorities
bBased on CENSUS 2011 data20
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missing ethnicity data on medical records and this group
was less likely to respond compared to patients of white
or south Asian ethnicity. Likelihood of response also re-
duced with increasing deprivation. Older age and male
sex predicted greater rates of response.
Strengths and limitations
The main strengths of the study are the large sample
size and the opportunity to assess response bias in a
multi-ethnic and socio-economically varied setting,
which few lifestyle intervention trials have achieved
[12]. Access to anonymised CVD risk and sociodemo-
graphic data of large numbers of non-responders,
including those who may typically be difficult to
reach and unlikely to provide research data, is a
unique aspect of this study. As a consequence of this
methodology we did not have informed consent to
access medical records for further information and so
there is a risk of residual confounding by employment
status, education and comorbidities [11]. We retrieved
data from approximately half of the participating gen-
eral practices, but as there was no difference in mean
general practice level deprivation compared with all
other practices in south London it is unlikely this was
a significant source of bias. Other studies have re-
ported more detailed data on a smaller number of
Table 2 Comparison of responders and non-responders to trial invite
All invited
n=8902a
Responded to
invitation
n = 1489
Did not respond
to invitation
n = 7413
Response
rate (%)
Unadjusted OR for
response to mailout
(95% CI)
Adjusted OR
for response to
mailout
(95% CI)
Test for
trend
(p)
Age at invitation (years) 67.3 (5.7) 68.1 (5.1) 67.2 (5.8) 1.14 (1.08, 1.21)b 1.19 (1.12, 1.26)b < 0.001
Age at invitation
40-59 yrs 976 (11.0%) 124 (8.4%) 852 (11.6%) 12.7
60-64 yrs 1462 (16.4%) 200 (13.5%) 1262 (17.0%) 13.7
65-69 yrs 2989 (33.6%) 536 (36.0%) 2453 (33.1%) 17.9
70-75 yrs 3475 (39.0%) 629 (42.2%) 2846 (38.4%) 18.1
Sex
Female 1847 (20.7%) 291 (19.5%) 1556 (21.0%) 15.8 1.00 1.00
Male 7055 (79.3%) 1198 (80.5%) 5857 (79.0%) 17.0 1.07 (0.93, 1.23) 1.25 (1.08, 1.45) 0.004
Ethnicity < 0.001c
White 6223 (69.9%) 1128 (75.8%) 5095 (68.7%) 18.1 1.00 1.00
Black African or Caribbean 272 (3.1%) 34 (2.3%) 238 (3.2%) 12.5 0.74 (0.50, 1.07) 0.67 (0.45, 0.98) 0.040
South Asian 578 (6.5%) 98 (6.6%) 480 (6.5%) 17.0 0.90 (0.70, 1.14) 1.08 (0.84, 1.38) 0.542
Other Asian 240 (2.7%) 31 (2.1%) 209 (2.8%) 12.9 0.69 (0.47, 1.03) 0.69 (0.46, 1.02) 0.066
Other/Mixed 147 (1.7%) 16 (1.1%) 131 (1.8%) 10.9 0.62 (0.36, 1.05) 0.61 (0.36, 1.04) 0.072
Missing 1442 (16.2%) 182 (12.2%) 1260 (17.0%) 12.6 0.58 (0.48, 0.69) 0.55 (0.46, 0.66) < 0.001
IMD 2010 quintile < 0.001c
1 (least deprived) 1407 (15.8%) 293 (19.7%) 1114 (15.0%) 20.8 1.00 1.00
2 1531 (17.2%) 285 (19.1%) 1246 (16.8%) 18.6 0.86 (0.70, 1.04) 0.87 (0.72, 1.07) 0.190
3 1616 (18.2%) 315 (21.2%) 1301 (17.6%) 19.5 0.80 (0.65, 0.98) 0.85 (0.69, 1.05) 0.139
4 2725 (30.6%) 420 (28.2%) 2305 (31.1%) 15.4 0.64 (0.52, 0.79) 0.70 (0.56, 0.87) 0.001
5 (most deprived) 1604 (18.0%) 171 (11.5%) 1433 (19.3%) 10.7 0.46 (0.23, 0.33) 0.52 (0.40, 0.68) < 0.001
Unknown 19 (0.2%) 5 (0.3%) 14 (0.2%) 26.3
QRisk2 score (%) 25.2 (5.0) 24.6 (4.5) 25.3 (5.1) 0.86 (0.81, 0.92)d 0.82 (0.77, 0.88)d < 0.001
20–24.9% 5357 (60.2%) 968 (65.0%) 4389 (59.2%) 18.1
25–29.9% 2245 (25.2%) 347 (23.3%) 1898 (25.6%) 15.5
> 30% 1300 (14.6%) 174 (11.7%) 1126 (15.2%) 13.4
OR odds ratio, CI confidence intervals, IMD Index of Multiple Deprivation
Data are presented as mean (SD) or n (%) unless otherwise stated
aAll patients invited to participate in the trial from GP practice sites at which it was possible to extract anonymised data
bOR per 5 year increase in age
cChi square test for independence
dOR per 5% increase in QRisk2 score
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non-participants, including qualitative feedback on
reason for non-participation [11, 15, 24–26], but the
current study benefits from an enhanced reach and
greater power to demonstrate response biases.
The methodology of recruitment to the MOVE IT trial
relied upon general practice database calculations of
QRisk2 score, and these calculations were used in the
current analysis. We did not seek ethical approval to as-
sess the underlying data used in the QRisk2 calculations.
It may be that large proportions of clinical data such as
blood pressure, weight and cholesterol:HDL ratio were
missing, which has been demonstrated previously [27],
in which case they would be replaced with age- and
sex-weighted averages. Additionally, where clinical data
is present, accuracy of QRisk2 scores may be compro-
mised by the length of time since clinical data had been
collected. In future analyses, the extraction of more de-
tailed data from medical records would allow for a sensi-
tivity analysis to explore the effect of missing or
outdated data on outcomes.
The use of a 20% QRisk2 score as a screening criteria led
to invitations to participate being sent to older, and more
male, patients as age and male sex are given a large weight-
ing in the QRisk2 algorithm [6]. Similarly, south Asian eth-
nicity contributes to an increased QRisk2 score and black
African or Caribbean ethnicity to a lower QRisk2 score
compared to white ethnicity. Therefore the use of an abso-
lute QRisk2 score as a screening tool in recruitment con-
tributed to limited demographic difference within the target
population. Alternative recruitment strategies may include
the specification of individual risk factors in the search
strategy [28], a relative CVD risk score incorporating a
comparison with the average score for an individual of the
same age, sex and ethnicity, or a lifetime CVD risk score
which tends to identify younger patients [29, 30]. These ap-
proaches may assist in identifying patients whose modifi-
able, rather than non-modifiable, risk factors suggest they
would benefit from the intervention as well as increasing
the likelihood of a more diverse and representative study
sample.
Interpretation and comparison with other studies
Previous studies have found both higher levels of
self-reported health and greater self-reported activity
levels [10, 14, 16, 17], as well as lower levels of self-
reported health, lower activity levels and a higher CVD
risk profile in participants compared to non-participants
[11, 13–15]. These contradictory findings may relate to
variations in recruitment methodology, the particular tar-
get population involved and the aims of the trial. As the
current study assessed those who did not respond to an
invitation and who are by definition hard to reach, we
could not compare self-reported physical activity or health
problems in responders and non-responders, but had the
advantage of reporting a standardised CVD risk algorithm
score. Already feeling healthy is a frequently cited cause of
non-participation [11, 15, 24–26], but using a QRisk2 cut-
off score of 20% in the current study meant that all those
invited to participate would be considered at high risk of
CVD [31], a fact which was communicated to patients in
the invitation letter. Those patients at the highest risk level
may not respond due to a number of reasons which could
be explored through qualitative work.
Previous studies have found greater response rates in
those of white ethnic background and those residing in
more affluent areas [11, 12], but the generalisability of
available data is limited due to the majority of partici-
pants in previous trials being white, middle-aged fe-
males, and the lack of information on ethnicity and
deprivation available in published trials [32]. Our find-
ings contribute to concerns that research in general fails
to reach socially disadvantaged groups [33]. However,
the trial did reach patients of south Asian ethnic back-
grounds as much as patients of white ethnic back-
grounds, which is a promising finding given higher CVD
risk in this group [34].
Ability to undertake an analysis of anonymised pri-
mary care data is limited by the large amount of missing
ethnicity data on general practice databases, and this im-
pacted the data collected for the current study. Provid-
ing self-report ethnicity data has been found to be less
likely in ethnic minority populations in the United States
[35], and ethnic minority patients are less likely to pro-
vide ethnicity information to health care providers due
to concerns over how the information may be used [36].
In a study of hospital patients with cancer in England,
there were only small differences in proportion of miss-
ing ethnicity data recorded in secondary care between
self-report ethnic backgrounds, and much larger differ-
ences were found between different hospitals [37]. The
missing ethnicity data in primary care may be related to
either general practice ethnicity-recording processes or
patient reluctance to divulge information, and further re-
search is needed to explore this and which patient
groups are more likely to have missing ethnicity data. In-
creasing ethnicity recording in primary care is vital for
understanding the representativeness of study samples.
Patients reluctant to provide optional self-report ethni-
city data in primary care may similarly be at reduced
likelihood of responding to a RCT invitation, as our
findings may allude to. Increasing awareness in certain
subgroups of the population through varied approaches
to recruitment, such as employing telephone or email
reminders for non-responders [38], or the assistance of a
recruitment mediator who is a member of the subgroup
[39], could help to improve study representativeness
amongst ethnic minority and less affluent groups.
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The majority of those invited to the trial were above
working age, and likelihood of response increased with
age. Burden of time is a common reason for non-
participation in lifestyle interventions [11, 24–26], and
older invitees are more likely to be retired and may have
more flexibility to participate. Other studies have found
that participation rate increases with age in working age
populations [15], but reduces into older age possibly as
patients become more frail [11, 16]. Tailoring a lifestyle
intervention for primary prevention of CVD may neces-
sitate changing the setting and target population from
primary care to the workplace, and making the interven-
tion more desirable by reducing time burden, increasing
flexibility and using digital technologies.
It has previously been reported that females are more
likely to participate in lifestyle intervention trials [11],
however reviews of the literature indicate many lifestyle
intervention trials have recruited female only samples [12,
32]. The higher response rate of males in the current
study, secondary to the larger proportion of males invited,
may reflect public opinion that CVD is a predominantly
male disease despite also being the leading cause of death
in females [5, 40]. Previous studies assessing participation
in trials of those who already have CVD [41, 42], and in a
survey regarding cardiovascular risk factors [43], also
found lower response in females. In a small sample of
those providing feedback on the reasons for non-
participation, females were more likely to mention caring
responsibilities as a barrier [41]. Increasing public aware-
ness of CVD risk in females, as well as providing flexible
appointments as previously mentioned, may be required
to increase female participation.
The findings of this study are specific to the RCT
under study, and should not be conflated with likelihood
of response to similar interventions in clinical practice.
Reasons for non-response may be research-specific, or
in combination with lack of motivation or interest in the
particular intervention. As participants were not con-
tacted for this analysis, we could not explore patient
perspectives on study-specific materials such as the
invitation letter sent by the patient’s general practice.
Further research is required to gain a greater under-
standing of the influence of study-specific invitation pro-
cedures, patient perspectives of research in general and
willingness to undergo an intervention.
Conclusions
We have demonstrated that it is possible to ethically as-
sess response bias to a RCT with the use of anonymised
patient data. As a result, we have highlighted the risk
that RCTs of lifestyle interventions may fail to recruit
the highest risk patients, ethnic minority patients and
those residing in more socioeconomically deprived areas,
which could result in implementation of interventions
which increase health inequalities. Such analyses are lim-
ited by missing ethnicity data on primary care databases.
Improvements in ethnicity reporting would aid under-
standing of whether RCTs have successfully recruited a
representative sample. Future RCTs of lifestyle interven-
tions should aim to proactively minimise recruitment
biases and report on the representativeness of their sam-
ples as part of a process evaluation.
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